# Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)

> **NCT03645525** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Children's Hospital of Fudan University**

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Human Umbilical Cord-derived Mesenchymal stem cell
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03645525
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-01
- **Primary completion:** 2022-10-30
- **Final completion:** 2023-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The certification of cell-based treatment in the settings need to be updated.
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03645525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03645525, "Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03645525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*